跳至主要内容
临床试验/NCT02443675
NCT02443675Unknown不适用

Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy

Cure Cancer Worldwide, LLC0 个研究点目标入组 300 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
主要终点
Pain Level Self Assessment

研究概览

简要总结

Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy

详细描述

Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient requests to be included in this study

排除标准

  • Patient does not request to be included in this study

结局指标

主要结局

Pain Level Self Assessment

时间窗: 5 years

From enrollment in study to termination of study (August 2020)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验